rifampin
Showing 1 - 25 of 146
COVID-19 Pneumonia Trial in Hangzhou (STI-1558, Itraconazole, Rifampin)
Not yet recruiting
- COVID-19 Pneumonia
- STI-1558
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Xiaoshan Hospital
Jan 5, 2023
Healthy Volunteers Trial in Changchun (Larotinib, Rifampin, Itraconazole)
Active, not recruiting
- Healthy Volunteers
- Larotinib
- +2 more
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Oct 26, 2022
Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)
Active, not recruiting
- Relapsed or Refractory Lymphoma
- HMPL-523
- +2 more
-
Austin, TexasPPD Austin
Jan 31, 2023
Healthy Participants Trial in Madison (AMG 510, Rifampin)
Completed
- Healthy Participants
- AMG 510
- Rifampin
-
Madison, WisconsinCovance Clinical Research Unit, Inc 3402 Kinsman Boulevard
Oct 10, 2022
Healthy Volunteers Trial (CC-92480, Rifampin, Itraconazole)
Recruiting
- Healthy Volunteers
- CC-92480
- +4 more
-
Dallas, TexasCovance Clinical Research Unit - Dallas
Oct 25, 2022
Healthy Participants Trial in Austin (Vonoprazan, Rifampin)
Withdrawn
- Healthy Participants
- Vonoprazan
- Rifampin
-
Austin, TexasPPD Development, LP, 7551 Metro Center Drive, Suite 200
Feb 10, 2022
Drug Drug Interaction Trial in Chengdu (SPH3127 tablet, Itraconazole, Rifampin)
Completed
- Drug Drug Interaction
- SPH3127 tablet
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital, Sichuan University
Jul 28, 2022
Healthy Volunteers Trial in Daytona Beach (LOXO-305, Itraconazole, Rifampin)
Completed
- Healthy Volunteers
- LOXO-305
- +2 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Nov 23, 2021
Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)
Recruiting
- Healthy Adults
- Sitravatinib 50 mg
- +3 more
-
Dallas, TexasLabcorp Drug Development Clinical Research Unit
Feb 23, 2022
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto
Recruiting
- Nontuberculous Mycobacterial Lung Disease
- Nontuberculous Mycobacterium Infection
- Hypertonic saline
- +3 more
-
New York, New York
- +2 more
Jan 27, 2023
Osteomyelitis, Diabetes, Amputation Trial in United States (Rifampin, Riboflavin Placebo)
Recruiting
- Osteomyelitis
- +2 more
- Rifampin
- Riboflavin Placebo
-
Phoenix, Arizona
- +29 more
Jan 13, 2023
Type 2 Diabetes Trial in Jilin (Rongliflozin, Rifampin, Probenecid)
Completed
- Type 2 Diabetes Mellitus
- Rongliflozin
- +2 more
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Aug 9, 2022
Type 2 Diabetes Trial in Daytona Beach (Bexagliflozin, Probenecid, Rifampin)
Completed
- Type 2 Diabetes Mellitus
- Bexagliflozin
- +3 more
-
Daytona Beach, FloridaCovance Clinical Research Unit
Jun 29, 2021
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)
Completed
- Pulmonary Tuberculosis
- PA-824
- +5 more
-
Cape Town, South AfricaUniversity of Cape Town Lung Institute
May 18, 2022